Jiao, Hongjie
Hao, Qi
Liu, Yu
Guo, Gang
Lu, Pengfei
Wu, Chuanchuan
Song, Chuanlong
Yue, Yingbin
Qi, Wenjing
Li, Jun
Zhang, Wenbao
Yan, Mei
Funding for this research was provided by:
Joint International Research Laboratory of Prevention and Control of Major Diseases in Central Asia,Xinjiang Medical University (JIRL-MDCA-2024-GH4)
National Natural Science Foundation of China (82160031)
Key Research and Development Project of Xinjiang Uygur Autonomous Region (2024B03038-1)
Etiological Exploration and Prognosis Prediction Cohort Study and Application Promotion of Immune Thrombocytopenia in Children (TSYC202301A002)
Article History
Received: 4 August 2025
Accepted: 10 April 2026
First Online: 15 June 2026
Declarations
:
: This study was approved by the Ethical examination and approval report No. 20210226-11 issued by the Ethics Committee of the first affiliated Hospital of Xinjiang Medical University on February 26th, 2021.I confirm that all research was performed in accordance with relevant regulations. Research involving human research participants I performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.